Cyclerion Therapeutics Inc
(CYCN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,954 | -44,078 | -36,862 | -26,366 | -12,978 |
| Depreciation Amortization | N/A | 65 | 65 | 65 | 48 |
| Accounts receivable | N/A | 4 | -127 | -127 | -127 |
| Accounts payable and accrued liabilities | 955 | 1,142 | -183 | 939 | 691 |
| Other Working Capital | 314 | -2,850 | -1,899 | -818 | -1,672 |
| Other Operating Activity | -529 | 5,106 | 5,438 | 2,654 | 1,203 |
| Operating Cash Flow | $-6,214 | $-40,611 | $-33,568 | $-23,653 | $-12,835 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $0 | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 29 | 17 | 17 | N/A |
| Financing Cash Flow | $N/A | $29 | $17 | $17 | $N/A |
| Exchange Rate Effect | 1 | 3 | -5 | -2 | -1 |
| Beginning Cash Position | 13,382 | 53,961 | 53,961 | 53,961 | 53,961 |
| End Cash Position | 7,169 | 13,382 | 20,405 | 30,323 | 41,125 |
| Net Cash Flow | $-6,213 | $-40,579 | $-33,556 | $-23,638 | $-12,836 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,214 | -40,611 | -33,568 | -23,653 | -12,835 |
| Free Cash Flow | -6,214 | -40,611 | -33,568 | -23,653 | -12,835 |